Americans look to Canada for lower drug prices, but are they getting the full picture?: Nigel Rawson and John Adams in The Hill
This article originally appeared in The Hill. The full article can be read here. By Nigel Rawson and John Adams, ...
Tag: drug policy
Waiting for new drugs for rare disorders in Canada, part 5 – Patented Medicine Prices Review Board: Nigel Rawson and John Adams for Inside Policy
This article is the fifth part of an 8-part series from the authors. The series, Waiting for new drugs for rare ...
Waiting for new drugs for rare disorders in Canada, part 4 – government drug plan listing: Nigel Rawson and John Adams for Inside Policy
This article is the fourth part of an 8-part series from the authors. The series, Waiting for new drugs for rare ...
Waiting for new drugs for rare disorders in Canada – part 3, price negotiation: Nigel Rawson and John Adams for Inside Policy
This article is the third part of an 8-part series from the authors. The series, Waiting for new drugs for ...
Waiting for new drugs for rare disorders in Canada – part 2, health technology assessment: Nigel Rawson and John Adams for Inside Policy
This article is the second part of an 8-part series from the authors. The series, Waiting for new drugs for ...
-
The Rupture Cycle – Commodities, geopolitics, and Canada’s moment: Heather Exner-Pirot
-
Canada’s conversation about new submarines is failing to ask the most important question: Rob Huebert in The Globe and Mail
-
Rebalancing Canada: A two-pillar reform of equalization and federal transfers
-
The most overlooked aspect of the new West Coast pipeline could be the most consequential: Jack Mintz in The Hub
-
A threat from within – Why NATO should suspend Türkiye: Isabelle Terranova
